Industry News

28 August 2015

Global Expansion: Opportunities in the U.S for Indian Companies

(Business Wire India); Brickwork India, the India representative of Fairfax County Economic Development Authority (FCEDA) organized the seminar on Global Expansion in Bangalore on July 23rd 2015. The seminar, conducted with the Indo-American Chamber of Commerce (IACC), highlighted the business opportunities in Fairfax County, Virginia – just outside Washington, DC – for Indian firms with IT services and solutions for the Cloud Computing, Big Data Analytics and Defence and Aerospace domains.
- Read more about Ajanta Pharma awarded by 3rd largest wealth creator from Fortune India
Ajanta Pharma, a Rs. 1,450 crore plus Mumbai based pharma major, has received the third largest wealth creator award from Fortune India. Fortune India has published list of 500 mid-size companies and ranked them on various parameters based on the results of 2013-14. Similarly, Ajanta Pharma ranked tenth on return on capital employed, 21st in net profit and 182nd in sales.

[adsense:336x280:8701650588]
- Read more about USFDA approves Marketing of Aurobindo Pharma’s Ulcer Drug
The US Food and Drug Administration (USFDA) has approved Aurobindo Pharma to market generic version of Prilosec delayed-release capsules used to treat ulcer.
- Read more about Amneal launch aripiprazole oral solution in US market
Amneal Pharmaceuticals LLC, a global supplier of generic pharmaceuticals launch aripiprazole oral solution in 1 mg/ml strength.
25 August 2015

In India OXXY launch hospital chain

OXXY, with over 1 lakh medical centres already tied up under its belt, is all set to launch its hospital chain in India. OXXY, valued over USD 2 billion, is all set to launch hospitals in the metros and a few other cities under its belt in next few months. These hospitals will be from 50 bedded to 500 bedded capacity. No other model currently exists in India and its success will purely depend on the affordability of quality treatment and services directly in comparison with the global standards.
- Read more about Trivitron Healthcare honoured with 'Make in India award' for medical device manufacturing
Trivitron Healthcare, India’s largest medical technology company was honoured with 'Make In India Awards for Excellence' in the medical device manufacturing category.

[adsense:336x280:8701650588]
- Read more about Eli Lilly in US market launch mealtime insulin analog, Humalog U-200 KwikPen
Eli Lilly and Company, a global healthcare leader, has launched
Humalog 200 units/ml KwikPen (insulin lispro 200 units/m; U-200), the first and only concentrated mealtime insulin analog in the US.
- Read more about US FDA receive Teva's NDA for SD-809 to treat Huntington disease
The US Food and Drug Administration (FDA) has accepted leading global pharmaceutical company, Teva Pharmaceutical Industries Ltd's New Drug Application (NDA) for SD-809 (deutetrabenazine) for the treatment of chorea associated with Huntington disease (HD). It is a rare and fatal neurodegenerative disorder caused by the progressive breakdown of nerve cells in the brain that affects about five to seven people per 100,000 in western countries, according to the World Health Organisation.
- Read more about US FDA approves BioDelivery Sciences' new formulation of Onsolis CII
focus in the areas of pain management and addiction medicine, announced the approval by the US Food and Drug Administration (FDA) of a Supplemental New Drug Application (sNDA) for a new formulation of Onsolis (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant. Onsolis is separately licensed by BDSI in Taiwan and South Korea.
- Read more about In India Dabur launches 'Dengue Fighters' initiative to prevent school kids from dengue
Dabur India Ltd, in an effort to ensure maximum use of its leading mosquito repellant Odomos, has unveiled the Dengue-Fighters initiative aimed at preventing school-going children across the country. The company along with Apollo Hospitals Group began its campaign in Bengaluru, which will then cover schools across Delhi, Uttar Pradesh, Maharashtra and Tamil Nadu.